NMT Capital

Overview

NMT Capital, formerly known as Nexus Medical Partners, is a globally oriented private equity firm managing investment funds in Europe and the United States. The firm focuses on companies with superior technology or business strategies, investing across various sectors including medical devices, diagnostics, biotechnology, specialty pharmaceuticals, drug discovery tools, software, communications, information technology, and advanced materials. NMT Capital is active globally, considering both domestic and offshore investments, particularly in companies located in Europe, the Middle East, and Asia seeking to enter the U.S. market. The firm is managed by experienced professionals with extensive backgrounds in investment management and advisory roles, supported by advisors and affiliates in Norwell (MA), San Francisco, London, Munich, Geneva, and Tokyo. NMT Capital has managed assets valued at over $1 billion during its career. The firm's investment approach is proactive, aiming to achieve maximum returns for investors by seeking out the best investment opportunities rather than waiting for them to find the firm. NMT Capital emphasizes strong syndicates and has co-invested with over 50 national and international investment firms. Once an investment decision is made, the firm dedicates significant time, energy, and resources to assist portfolio companies in succeeding. Beyond providing capital, NMT Capital leverages its experience and international network to give companies a competitive advantage in their respective markets. For example, the firm has invested in a company that is replacing animal testing with complex in vitro assays, introducing the company to European firms engaged in complementary and synergistic businesses to accelerate growth and access wider capital markets. In the current investment landscape, NMT Capital recognizes that profitable liquidity events are less common, and successful exits often result from investors' efforts to mold portfolio companies into attractive acquisition targets. The firm utilizes its substantial experience in private equity fund management and its extensive network of contacts in the U.S., Europe, and Asia to assist companies in achieving exits, cross-border licensing transactions, and corporate collaborations. This strategic approach underscores NMT Capital's commitment to fostering growth and value creation for its portfolio companies across diverse global markets.

Investment Focus

• Strong management team
• Innovative technology or business strategy
• Potential for international expansion